Clinical trials of probiotics: Current outlook
Haitham Al‐Madhagi, Abir Alramo · 2023
Read Clinical trials of probiotics: Current outlook by Haitham Al‐Madhagi, Abir Alramo (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10916572.txt.
Description
Haitham Al-Madhagi and Abir Alramo survey the state of clinical trials of probiotics in a 2023 letter. Probiotics are living microbes taken for health benefit. The gut hosts a vast community of bacteria, archaea, and yeasts that support digestion, immunity, and even nervous system balance. Trialed probiotics mostly come from raw milk and fermented foods such as yogurt and pickles.
The letter sums up how these microbes are thought to act: crowding out harmful bacteria, competing for food, releasing microbe killing compounds, and helping digest fibers the body cannot handle alone. Some also reshape the immune system or release useful compounds. To serve as probiotics, the microbes must survive the trip through the gut. The authors review what trials worldwide have tested and what became of them.
Catalog record
| CREATOR | Haitham Al‐Madhagi, Abir Alramo |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 7 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |